United Airway Disease: Current Perspectives

Dear Colleagues,

We are pleased to announce this Special Issue, which is aimed at enhancing the central role of the respiratory system in regulating homeostasis of the whole body. Also, when dysregulated, it is responsible for a significant socioeconomic burden and several clinical conditions with possible multi-organ failure may occur.

Searching for possible associations between different respiratory disorders, such as nasal congestion, allergy and asthma, entails personalizing medical treatment. Identifying the inflammatory profile of diseased patients contributes to predicting the effectiveness of medical and surgical therapeutic strategies. Also, studying the interaction between respiratory symptoms and poor sleep quality, asthenia, restlessness, or drowsiness may help intercept undiagnosed sleep disorders, thus preventing the serious cardiovascular consequences of sleep apnoea.

Nowadays, interest in the respiratory systems is increasing, as specialists are facing ever more clinical challenges. Recent advances in clinical immunology, which resulted in the approval of monoclonal antibodies for the treatment of chronic severe type-2 inflammation, have boosted this process further. These challenges entail the creation of multidisciplinary approaches aimed at keeping the patient at the centre of the treatment plan, from diagnostics to treatment proposals and follow-up (i.e., participation).

From this standpoint, this Special Issue is focused on exploring current perspectives, as well as on shining a spotlight on the most recent advances in both the diagnostic and therapeutic aspects of united airway diseases. As such, we invite the submission of contributions by different specialists whose professional experience encompasses a multidisciplinary approach to such conditions (e.g., allergologists, pneumologists, rhinologists, etc.), bearing in mind a personalized medicine approach. 

Prof. Dr. Luca Malvezzi
Prof. Dr. Manuele Casale
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• chronic rhinosinusitis
• asthma
• personalized medicine
• type-2 inflammation
• united airway
• obstructive sleep apnoea
• monoclonal antibodies
• endotype
• rhinology